Skye Bioscience, Inc. Additional Paid in Capital, Common Stock
Skye Bioscience, Inc. (SKYE) had Additional Paid in Capital, Common Stock of $209.64 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2026-08-14
- 2026-06-30: Additional Paid in Capital, Common Stock $209.64M.
- 2026-03-31: Additional Paid in Capital, Common Stock $208.36M.
- 2025-12-31: Additional Paid in Capital, Common Stock $206.87M.
- 2025-09-30: Additional Paid in Capital, Common Stock $205.24M.
| Period end | Additional Paid in Capital, Common Stock | Additional Paid in Capital, Common Stock as first filed |
|---|---|---|
| 2026-06-30 | $209.64M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $208.36M 10-Q · filed 2026-05-11 | |
| 2025-12-31 | $206.87M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $205.24M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $203.32M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $201.27M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $199.07M 10-K · filed 2026-03-10 | |
| 2024-09-30 | $196.98M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $190.09M 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $188.26M 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $102.24M 10-K · filed 2025-03-20 | |
| 2023-09-30 | $101.65M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $66.26M 10-Q · filed 2023-08-07 | |
| 2023-03-31 | $66.15M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $63.73M 10-K · filed 2024-03-22 | $62.82M 10-K · filed 2023-03-31 |
| 2022-09-30 | $53.07M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $52.92M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $52.78M 10-Q · filed 2022-05-06 | |
| 2021-12-31 | $52.64M 10-K · filed 2023-03-31 | |
| 2021-09-30 | $52.53M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $44.79M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $43.01M 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $38.90M 10-K · filed 2022-03-28 | |
| 2020-09-30 | $38.84M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $32.66M 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $32.63M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $32.54M 10-K · filed 2021-03-02 | |
| 2019-09-30 | $20.49M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $20.32M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $17.99M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $17.53M 10-K · filed 2020-03-23 | $16.23M 10-K · filed 2019-03-14 |
| 2018-09-30 | $15.73M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $15.55M 10-Q · filed 2018-08-10 | |
| 2018-03-31 | $15.38M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $9.44M 10-K · filed 2019-03-14 | |
| 2017-09-30 | $9.16M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $8.98M 10-Q · filed 2017-08-11 | |
| 2017-03-31 | $8.33M 10-Q · filed 2017-05-12 | |
| 2016-12-31 | $7.16M 10-K · filed 2018-03-19 | |
| 2016-09-30 | $6.64M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $6.45M 10-Q · filed 2016-08-12 | |
| 2016-03-31 | $6.27M 10-Q · filed 2016-05-13 | |
| 2015-12-31 | $6.09M 10-K · filed 2017-03-10 | |
| 2015-09-30 | $5.72M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $4.32M 10-Q · filed 2015-08-14 | |
| 2015-03-31 | $3.28M 10-Q · filed 2015-05-13 | |
| 2014-12-31 | $2.26M 10-K · filed 2016-03-21 | |
| 2014-07-31 | $83.08K 10-Q · filed 2014-09-15 | |
| 2014-04-30 | $83.08K 10-Q · filed 2014-06-05 | |
| 2014-01-31 | $83.08K 10-Q · filed 2014-03-17 | |
| 2013-10-31 | $83.08K 10-Q · filed 2014-09-15 | |
| 2012-10-31 | $35.57K 10-K · filed 2014-01-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |